Navigation Links
New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting-Edge Treatment to Satellite Communities
Date:9/10/2009

ltiple births. Following a referral from a pediatrician, neurosurgeon, or other specialist, infants with plagiocephaly or a related condition, such as brachycephaly or scaphocephaly, are evaluated by a practitioner at the STAR Cranial Center of Excellence, scanned with the state-of-the-art STARscanner, and treated when necessary with a STARband cranial remolding orthosis. In cases where an infant's plagiocephaly is considered mild, or if the practitioner believes the infant is young enough, the practitioner may recommend that the patient be rescanned after several weeks of repositioning efforts to see if the infant's head shape improves without STARband treatment.

STARband cranial remolding helmets, also commonly referred to as a cranial remolding orthoses or headbands, are worn 23 hours per day for three to six months, channeling head growth by applying constant, gentle contact on protruding areas of the head, while leaving room for growth in flattened areas. The helmet is adjusted every two to three weeks to account for growth and head shape changes. Infants adapt well to the STARband.

The STAR Cranial Center of Excellence exclusively uses the STARscanner system, which scans a child's head in less than two seconds. It is faster, cleaner, more accurate, and less stressful for infants than the traditional plaster casting technique. The STARscanner provides detailed measurements and objective head shape data that is helpful for the patient's family, referring physician, and practitioner to review when determining the need for treatment. The STARscanner also documents head shape changes before, during, and after treatment.

Early recognition of head shape abnormalities is critical for optimal treatment results. Treatment for plagiocephaly is most effective if begun at four to six months of age. Some physicians believe that lack of treatment can lead to developmental delays, visual impairment and misaligned
'/>"/>

SOURCE Orthomerica Products, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. CONCERTA(R) (methylphenidate HCl) LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS
2. CONCERTA(R) (methylphenidate HCI) LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS
3. Nurses Facing National Shortage Turn to Mobile Technology to Support Patient Care
4. Choco Milk Initiates Adventure-Filled Mobile Tour That Teaches Children Nutrition Awareness
5. Dont Miss Twinlabs(R) 2009 Mobile Beach Bash Grand Finale Celebration Labor Day Weekend
6. Mom & Baby Mobile Health Centers Have Become Primary Care Providers Along the Gulf Coast
7. Mobile MedCheck Brings Back House Calls
8. Lagan Increases Productivity of Case Management Workers in the Field; Saves Time and Money for Human Services Agencies with Lagan Mobile(TM)
9. Ingenious Meds IM Quality(TM) Solution Goes Mobile
10. Verizon Wireless Offers Healthy Applications to Turn a Mobile Phone Into a Personal Trainer
11. ASAP Systems Introduces Mobile RFID Technology for its Passport Assets Application Enabling Increase Asset Management Flexibility
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Growth hormone is used to treat twice as many short boys than girls in the US and Asia 2Health News:Growth hormone is used to treat twice as many short boys than girls in the US and Asia 3Health News:Anthem Blue Cross and Blue Shield Celebrates Local Moms-to-Be at Community Baby Shower 2Health News:The Best Things in Life Are ... In Better Health & Living(R), A Free, Premium Magazine Launching April 26 in the Twin Cities 2Health News:The Best Things in Life Are ... In Better Health & Living(R), A Free, Premium Magazine Launching April 26 in the Twin Cities 3Health News:U-M study: Work hassles hamper sleep 2Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 2Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 3Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 4Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 5Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 6Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 7Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 8Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 9Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 10Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 11Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 12Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 13Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 14Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 15Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 16Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 17Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 18Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 19Health News:Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36 20Health News:Arpida Provides Comprhensive Overview of Pivotal Phase III Trial Data 2Health News:Arpida Provides Comprhensive Overview of Pivotal Phase III Trial Data 3
Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 2Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 3Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 4Courage Center Presents 2009 National Courage Award to Jordan Thomas 53961 1Courage Center Presents 2009 National Courage Award to Jordan Thomas 53961 2Courage Center Presents 2009 National Courage Award to Jordan Thomas 53961 3Beetroot Juice May Boost Stamina 53957 1Beetroot Juice May Boost Stamina 53957 2Insulet Corporation to Present at Upcoming Investor Conferences 53953 1Insulet Corporation to Present at Upcoming Investor Conferences 53953 2